Primary and key secondary efficacy endpoints
SECONDARY
Results of primary and key secondary endpoints are presented in Efficacy outcome measures by treatment groupAbbreviations: CGI-I, Clinical Global Impressions-Improvement; CI, confidence interval; IRLS, International RLS Study Group Rating Scale; MOS-I, Medical Outcomes Study Sleep Problem Index I; MOS-I, Medical Outcomes Study Sleep Problem Index II; NA, not applicable; PGI-I, Patient-Global Impressions-Improvement; TOMAC, tonic motor activation.Comparison of Efficacy Endpoints between TOMAC and Sham. Comparison of response to TOMAC and Sham assessed at Week 4 compared to baseline for the following efficacy endpoints: A. CGI-I responder rate, B. PGI-I responder rate, C. IRLS total score, D. MOS-II score, E. MOS-I score, F. CGI-I mean score. Error bars represent standard error of means and proportions.